Estimaciones de analistas de Wall Street para Rapid Micro Biosystems, Inc. (RPID): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-06 | $-0.19 | ||
| 2026-08-07 | $-0.27 | $-0.24 | -11.0% |
| 2026-05-13 | $-0.31 | $-0.25 | -24.0% |
| 2026-03-12 | $-0.28 | $-0.23 | -21.7% |
| 2025-11-07 | $-0.26 | $-0.26 | +0.0% |
| 2025-08-12 | $-0.27 | $-0.26 | -3.8% |
| 2025-05-09 | $-0.26 | $-0.27 | +3.7% |
| 2025-02-28 | $-0.22 | $-0.22 | +0.0% |
Ratios de valoración
| Precio / Valor contable | 2.91 |
| EV / EBITDA | -1.47 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Ingresos | $16.5M | $16.1M | $23.2M | $17.1M | $22.5M | $28.1M | $33.6M |
| Coste de Ventas | $16.7M | $24.1M | $31.0M | $25.7M | $28.0M | $28.2M | $26.0M |
| Beneficio Bruto | -$234000 | -$8.1M | -$7.7M | -$8.5M | -$5.5M | -$109000 | $7.6M |
| I+D | $5.4M | $6.5M | $9.8M | $12.9M | $12.8M | $14.6M | $13.6M |
| Generales y Administrativos | $13.0M | $15.9M | $29.7M | $41.8M | $38.3M | $35.2M | $34.8M |
| Gastos Operativos | $18.4M | $22.5M | $39.5M | $54.7M | $51.1M | $49.8M | $55.0M |
| Beneficio Operativo | -$18.6M | -$30.5M | -$47.2M | -$63.2M | -$56.6M | -$49.9M | -$47.4M |
| EBITDA | -$16.9M | -$32.0M | -$69.3M | -$58.5M | -$49.3M | -$43.5M | -$42.7M |
| Gastos por Intereses | $2.4M | $3.4M | $2.6M | 0 | 0 | 0 | $1.1M |
| Beneficio Antes de Impuestos | -$20.7M | -$36.9M | -$73.4M | -$61.4M | -$52.4M | -$46.9M | -$47.1M |
| Impuestos | $427000 | $134000 | $91000 | -$576000 | $31000 | $22000 | $40000 |
| Beneficio Neto | -$21.2M | -$37.1M | -$73.5M | -$60.8M | -$52.5M | -$46.9M | -$47.1M |
| BPA | $-0.53 | $-1.17 | $-1.88 | $-1.43 | $-1.22 | $-1.08 | $-1.05 |
| BPA Diluido | $-0.53 | $-1.17 | $-1.88 | $-1.43 | $-1.22 | $-1.08 | $-1.05 |
| Acciones en Circulación (Diluidas) | $39.7M | $38.7M | $41.5M | $42.5M | $43.0M | $43.6M | $44.7M |
Precio
| Precio | $1.12 |
| Capitalización | $51M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: APYX · CGTX · LNSR · LUCD · NSPR · OWLT · RCEL
Explorar sector: Healthcare · Medical - Devices
Más secciones de RPID: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones